Phospho-PTEN (Ser380) (NA9) rabbit mAb

Catalog #: 2236
Select Your Size Price
200 uL (0.5 mg/mL)(2236-200) $570.00
20 uL (0.5 mg/mL)(2236-20) $210.00
From $210.00

Need to make a custom order?

Contact us


20 μL is enough antibody for at least 20 Western blots.

Product Overview

PTEN has been identified as a tumor suppressor gene and has been found to be mutated in a significant number of human cancers, including prostate, brain, and breast cancer. PTEN shares sequence homology with the protein-tyrosine phosphatase (PTPase) family of proteins and negatively regulates the PI3K/Akt pathway. PTEN de-phosphorylates target proteins, and recombinant PTEN has been shown to have phosphoinositide 3-phosphhatase and inositol phosphate 3-phosphatase activity. Studies of primary tumor cells show a loss of PTEN expression after metastasis to the brain, via astrocyte-derived microRNAs. A cluster of phosphorylation sites (S380, T382, T383, and S385) in the C-terminal tail of PTEN drive a conformational change that reduces PTEN activity by inhibiting membrane interactions.

Product Details

Product Details
Specification Description
Applications Flow Cytometry
Clone PTENS380-NA9
Format Unconjugated
Validated Reactivity Human, Mouse
Cross Reactivity Predicted to work with mouse, rat, and other homologues.
Detection Anti-Rabbit IgG
Clonality Monoclonal
Immunogen A synthetic phospho-peptide corresponding to residues surrounding Ser380 of human phospho PTEN
Formulation 1X PBS, 0.02% NaN3, 50% Glycerol, 0.1% BSA
Isotype Rabbit IgGk
Preparation Protein A+G
Recommended Usage 1µg/mL – 0.001µg/mL. It is recommended that the reagent be titrated for optimal performance for each application. See product image legends for additional information.
Storage -20ºC
Pseudonyms Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase, Mutated in multiple advanced cancers 1, MMAC1, Phosphatase and tensin homolog, TEP1
Uniprot ID P60484
References Li J, Yen C, Liaw D, et al. (1997) Science. 275:1943-1947.
Maehama T, and Dixon JE. (1998) Journal of Biological Chemistry. 273:13375-13378.
Zhang L, Zhang S, You J, et al. (2015) Nature. 527:100-104.
Chen Z, Dempsey DR, Thomas SN, Hayward D, Bolduc DM, and Cole PA. (2016) Journal of Biological Chemistry. 291:14160-14169.


Cell Culture Products
Flow cytometric analysis of A431 cells, untreated and unstained as negative control (blue) or untreated and stained (green) or treated with lambda phosphatase and stained (red) using Phospho-PTEN (S380) antibody, PTENS380-NA9 at 0.1 ug/mL, Cat. #2236.
Cell Culture Products
Peptide blocking flow cytometric analysis of A431 cells secondary antibody only negative control (light blue) or untreated (red) or treated with EGF (green) or untreated and blocked with phospho-peptide (black) or EGF and blocked with phospho peptide (gold) or untreated and blocked with non-phospho peptide (dark blue) or EGF and blocked with non-phospho peptide (purple) using Phospho-PTEN (S380) antibody PTENS380-NA9 0.05 µg/mL. Cat. #2236.
Cell Culture Products
PTENS380-NA9 recognizes basal phosphorylation levels in mouse cells. Flow cytometric analysis of L929 cells secondary antibody only (blue) or 0.1 µg/mL of isotype control Cat. #2141 (orange) or of Phospho-PTEN (S380) antibody PTENS380-NA9 (green) Cat. #2236.

Associated Products